Growing Popularity of the Global Stem Cells Market

Stem cells are a special category of cells in multicellular organisms that have the ability to differentiate into multiple cells through the process of mitosis. The global stem cells market has immense potential for growth, especially in the medical field, as governments have been focusing on dedicated clinical activities.

Browse report : http://www.transparencymarketresearch.com/stem-cells-market.html



Therapeutic research activities boosting the stem cells market
There has been growing awareness across regions regarding the importance of stem cells and stem cell banking services, significance of stem cells in drug discovery and development, and regenerative treatment options. This, backed by government support, has triggered a spurt in therapeutic research activities in the field of stem cells, thereby driving the global market. Rising number of patients with neurodegenerative disorders, growing trend of replacing animal tissue in drug discovery, and an expanding contract research industry are potential growth opportunities for the stem cells market. On the other hand, high cost of treatment and government laws regarding unethical harvesting of stem cells is expected to restrain the market.



Stem cells market – A highly fragmented industry
The global stem cells market can be segmented on the basis four main parameters: product, technology, application, and geography. On the basis of products, the stem cell market is divided into adult stem cell, induced pluripotent stem cell, rat neural stem cell, human embryonic stem cell, and very small embryonic-like stem cell. Adult stem cells are further segmented into hematopoietic stem cell, neuronal stem cell, dental stem cell, mesenchymal stem cell, and umbilical cord stem cell. On the basis of application, the stem cells market is broadly categorized as drug discovery and development and regenerative medicines. Regenerative medicines is further segmented into injuries, neurological disorders, Crohn’s disease, orthopedics, cancer, organ transplants, incontinence, infertility, diabetes, hematological disorders, liver disorders, cardiovascular and myocardial infarction, and immunodeficiency disorders. On the basis of technology, the stem cells market is segmented into stem cell expansion and sub-culture, stem cell cryopreservation, stem cell acquisition, and stem cell production. On the basis of geography, the global stem cells market is divided into North America, Europe, Asia-Pacific, and Rest of the World.



Adult stem cells most flourishing segment
At over 80%, the adult stem cells segment accounted for a majority of the overall stem cells market owing to fewer chances of contamination during stem cell expansion and sub-culture, and fewer hassles while harvesting. However, the induced pluripotent stem cells segment is expected to grow at a relatively faster CAGR due to lesser post-transplant complications and fewer risks of graft-versus-host reaction. Among the major applications, regenerative medicines led the overall stem cells market in 2011 and will continue to dominate the scene owing to significant research and resultant therapies in the field of neurology.



North America heading the global market
The continuous and tremendous support by the government in North America makes it the leader of the global market. Termed as the center of stem cells research, the region has developed over the years due to higher affordability of treatment. The European stem cells market is also gaining prominence due to higher incidences of chronic diseases and research investments from government and private organizations. However, factors such as improving economic stability, rising disposable income, growing medical tourism in emerging countries such as China and India, migration of patients from the U.S. and Europe for cheaper yet quality treatment, flourishing contract research industry, and high rate of chronic diseases is expected to propel the stem cells market in Asia.



Industry leaders



The key players of the global stem cells market include California Stem Cell Inc., Cellular Engineering Technologies, Biotime Inc., Brainstorm Cell Therapeutics, Cytori Therapeutics Inc., Celgene Corporation Inc., Bioheart, Cellartis AB, Osiris Therapeutics, Angel Biotechnology, Advanced Cell Technology, and Stemcelltechnologies Inc.
According to a recent report published by a market intelligence company, the worldwide stem cells market was valued at US$26.23 billion in the year 2013 and is forecast to be worth US$119.52 by 2019, growing at a CAGR of 24.2%.



Request a Sample of this Report :http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=132

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Global Biotechnology Market to Value USD 414.5 Billion 2017: Transparency Market Research

Transparency Market Research has added a new market intelligence report on the global Biotechnology Market titled, "Biotechnology Market by Application (Biopharmacy, Bioservices, Bioagri, Bioindustrial), by Technology (Fermentation, Tissue Regeneration, PCR, Nanobiotechnology, DNA Sequencing & Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2010 - 2017" to its datastore. The report states that the global market for biotechnology, studied according to its application areas, shall grow at an average annual growth rate of CAGR 11.6% from 2012 to 2017 and reach a value worth USD 414.5 billion by the end of 2017. This market was valued approximately USD 216.5 billion in 2011.

Browse Full Biotechnology Market Research Report with Complete TOC: http://www.transparencymarketresearch.com/biotechnology-market.html

Simply stated, biotechnology is the branch of technology that is based on biology. By harnessing biomolecular and cellular processes for developing products and technologies that have the potential of improving our lives as well as the health of our planet, biotechnology presents before us an interesting fusion of the natural and the man-made world. Biotechnology has been employed by the human race for more than 6000 years now - since the time a variety of microorganisms were used for preparing breads, cheese, and for preserving dairy products.

However, the modern-world biotechnology has grown substantially and found applications in many complex processes such as manufacturing of vaccines that can effectively treat many previously untreatable medical conditions, for the production of biotechnologically cured seeds that substantially improve yields of crops across the world, for the sequencing of chromosomes to closely study DNA and understand their relation with many diseases in living beings, and many more.

For more inquiries, you can ask here: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=498

According to the new report on the global Biotechnology market by Transparency Market Research, this market is estimated to observe substantial growth during the forecast period, i.e. between 2010 and 2017. Global recession in the past five years had shadowed the biotechnology market and had shunned its growth. The demand for nonessential health products and funding for new biotechnology projects was vastly reduced.

Despite these factors, many biotechnological industries flourished by the virtue of technological advancements leading to new discoveries and rising demands from the pharmaceutical and agricultural sectors.

Related published reports by Transparency Market Research

Stem Cells Market: http://www.transparencymarketresearch.com/stem-cells-market.html

Epigenetics Drugs and Diagnostic Technologies Market: http://www.transparencymarketresearch.com/epigenetics-market.html

Forensic Technologies Market: http://www.transparencymarketresearch.com/forensics-technology.html

According to the new market intelligence report by Transparency Market research, the growth of this industry is estimated to skyrocket during the forecast period as investments from around the world are anticipated to rise, especially from emerging economical regions of the world. As per the report, this would partly be supported by rise in government funding for various biotechnological research and development projects and partly by the ever increasing demand for food from these countries. In fact, it is estimated that in the coming years, the demand of bioseeds is deemed to rise multiple times as compared to conventional seeds, spurring growth of the bioagriculture market. According to the report, the market of bioagriculture, combined with that of bioseeds, is projected to reach a value worth USD 27.46 billion by 2018.

Application-wise, the field of biopharmaceuticals dominated the global biotechnology market and accounted for 60% shares of it in the year 2011.

Browse full Press Release of this report: http://www.transparencymarketresearch.com/pressrelease/biotechnology-market.html

Rise in government funding, availability of cheap, eligible and abundant labor and widespread technological advancements has allowed developing economies such as India, Thailand and China in taking up healthcare contract research outsourcing works such as clinical research, clinical trials management, preclinical research, biopharmaceutical development, commercialization, etc.

Geographically, North America stood as the market leaders of this industry in the year 2011, accounting for an approximate 42% share of the global market. However, due to a rising focus on renewable chemicals, the region of Asia Pacific is estimated to grow at an annual CAGR of 14.1% during the forecast period.

About Us:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Transcriptomics Technologies Market is Expected to Reach USD 4.6 Billion Globally in 2019: Transparency Market Research

According to a new market report published by Transparency Market Research "Transcriptomics Technologies Market (Microarrays, PCR, Gene Regulation and Next Generation Sequencing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global transcriptomics technologies market was valued at USD 1.65 billion in 2012 and is expected to grow at a CAGR of 15.9% from 2013 to 2019, to reach an estimated value of USD 4.6 billion in 2019.

Browse the full report with Complete TOC at http://www.transparencymarketresearch.com/transcriptomics-technologies-market.html

Transcriptome refers to the complete set of all coding and non-coding ribonucleic acid (RNA) molecules present in an individual or population of cells. Transcriptome accounts for about less than 5% of the total genome. Transcriptomics research refers to the study of functional and structural aspects of RNA transcripts in a given cell. This research provides insights about the gene expression and gene regulation mechanisms in normal and diseased cells such as cancerous cells. In addition it aids in identification of novel gene sequences and potential drug targets. With the increasing preference for personalized medicine and companion diagnostics, transcriptome technologies promises increased participation of pharmaceutical and biotechnology companies in healthcare and medical research projects. The most important factors favoring growth of global transcriptomics market include consistent technological upgradation followed by increased healthcare and R&D expenditure by pharmaceutical and biotechnology companies. Also, continuous exploration of biomarkers and novel gene sequences will drive the growth and acceptance of transcriptomics technologies across the globe.

Lack of effective bioinformatics tools employed for transcriptome analysis is one of the major factors expected to hamper the ready acceptance of transcriptome analysis tools and services. In addition, lack of awareness about genomic medicine and domain expertise are the other factors which might restrain the market growth. Increased research investments made by several pharmaceutical and biotechnology companies to develop targeted therapeutics, provide a growth opportunity to the transcriptomics technologies. Currently, the trend of contract research outsourcing is advantageous for the development and commercialization of transcriptomics research outcomes.

The global transcriptomics technologies market can be categorized by technology, application and geography. RNA sequencing technologies have surpassed the usage of microarrays in drug discovery and research with increased efficiency and reliability. Transcriptomics technologies market for microarrays was the most prominent segment of the market in 2012 by revenue. However, next generation sequencing technologies are steadily surpassing the use of microarrays, owing to their higher efficiency, reliability and capabilities. Extensive research activities and technological evolution of sequencing platforms further propel adoption of next generation sequencing technologies. Another attractive segment of this market is that of gene regulation technologies such as micro RNA and RNA interference technology. These technologies regulate proper functioning of the genes in normal as well as diseased cells. It is estimated that the market for gene regulation technologies will grow at a CAGR of over 15% from 2013 to 2019.

At the regional level, North America was the largest market in 2012 for transcriptomics technologies followed by the European region. Presence of sophisticated and well infrastructured research and medical laboratories followed by increased participation of respective governments in healthcare sector will propel growth and acceptance of transcriptomics research in North American market. The Asia-Pacific region is expected to record commendable growth by 2019 due to huge untapped potential population, rising disposable income, increased healthcare investments and extensive research carried out in the biotechnology field.

Transcriptomics technologies market is characterized by the presence of established players as well as new players solely operating in this market. The major companies competing in this market are Agilent Technologies, Inc., Affymetrix, Inc., Life Technologies Corporation, Illumina, Inc., F-Hoffmann La Roche Ltd. and Thermo Fisher Scientific.

Related Published Reports by Transparency Market Research

Atrial Fibrillation Market: http://www.transparencymarketresearch.com/atrial-fibrillation-market.html

Freeze Drying Equipment Market: http://www.transparencymarketresearch.com/freeze-drying-equipment-market.html

Metal Cans Market: http://www.transparencymarketresearch.com/metal-cans-market.html

The global transcriptomics technologies market is segmented as follows:

Transcriptomics Technologies Market, by Technology

Microarrays

Polymerase Chain Reaction (PCR)

Gene Regulation Technologies (mRNA and RNAi technology)

Next Generation Sequencing (NGS) technologies

Request a Sample of this Report :http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1659

Transcriptomics Technologies Market, by Application

Clinical Diagnostics

Drug Discovery and Research

Bioinformatics

Comparative Transcriptome studies

Transcriptomics Technologies Market, by Geography

North America

Europe

Asia-Pacific

Rest of the World (RoW)

Browse all Pharmaceutical Market Research Reports @ http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Cell Culture Market is Expected to Reach USD 16.85 Billion Globally in 2018: Transparency Market Research

According to a new market report published by Transparency Market Research "Cell Culture Market (Media, Sera, Reagents, Serum-free Media, Albumin, Growth Factors & Cytokines, Instruments, Bioreactors, Roller Bottle Equipment, T-flasks and Cryostorage Equipment) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," in 2011, the global cell culture market was valued at USD 8.5 billion and is expected to grow at a CAGR of 10.3% from 2012 to 2018, to reach an estimated value of USD 16.85 billion in 2018.

Browse the full report at http://www.transparencymarketresearch.com/cell-culture-the-world-market-for-media-sera-and-reagents.html

The growth of this market is driven by the shift towards use of live model systems for drug discovery and evaluation, use of animal-derived component free media and reagents, and growing demand for advanced biologics and biosimilars produced by biopharmaceutical manufacturers. Increasing demand for automated cell culture processes and systems will help boost growth in the cell culture instruments market. A shift towards contract manufacturing and research to cater to the ever-increasing demands of the healthcare sector with respect to advanced treatment options will further help fuel growth of this market during the forecast period from 2012 to 2018.

The market for serum-free media is the fastest growing segment with a CAGR of 21.1%. The adoption of serum-free, chemically defined and specialty media will be considerably high, driving growth of this segment. The bioreactor and culture system segments form the most attractive markets in the consumables segment, in terms of revenues as well as CAGR.

Geographically, North America constituted the major market for cell culture in 2011. This can be attributed to the presence of a large number of leading market players, high healthcare expenditure and availability of advanced technologies in the fields of biotechnology. However, Asia-Pacific is expected to be the fastest growing region, growing at a high CAGR of 15.6%, due to the emergence of many small regional players, lower operating costs as compared to developed markets and growing economies.
The global cell culture market is dominated by a small number of large players such as BD Biosciences, Corning Biosciences, EMD Millipore, Life Technologies Corporation, Lonza Group, Sigma-Aldrich Corporation and Thermo Fisher Scientific, Inc. In 2011, Life Technologies Corporation accounted for the largest market share, followed by BD Biosciences and EMD Millipore.

Request a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=405

The global cell culture market is segmented as follows:

Cell Culture Consumables Market, by Products


Media, by types
Chemically defined media
Classical media
Lysogeny Broth (LB)
Protein-free media
Serum-free media
Specialty media
Sera, by types
Fetal Bovine Serum
Other animal sera
Reagents, by types
Albumin
Amino acids
Attachment factors
Growth factors & Cytokines
Protease Inhibitors
Thrombin
Others

Cell Culture Instruments Market, by Products

Culture Systems, by types
Culture Bags
Culture Plates
T-flasks
Culture Dishes
Roller Bottles
Bioreactors
Incubators
Pipetting Instruments
Roller Bottle Equipment
Biosafety Cabinets
Cryostorage Equipment
Others

Cell Culture Market, by End Users

Academics & Research
Commercial Producers

Cell Culture Market, by Geography
North America
Europe
Asia-Pacific
Rest of the World (RoW)


Browse all Pharmaceutical Market Research Reports @ http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html


About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012- 2018

With growing incidences of cancer, Parkinson’s and Alzheimer’s disease, and metabolic disorders, the global peptide therapeutics market has received a significant boost. The application of peptide therapeutics in the field of biotechnology and pharmaceuticals offers tremendous potential as an emerging market and the research report analyses the numerous possibilities that lie before the global peptide therapeutics market.

Browse Report:http://www.transparencymarketresearch.com/peptide-therapeutics-market.html

Categorizing the peptide therapeutics market on the basis of type, application, route of administration, technology, and geography, the report individually evaluates each segment of the peptide therapeutics industry and offers key insights on the same. Data on key aspects such as market size, value, industry share, global outlook, trends, and past, current, and future statistics of the global peptide therapeutics market have been provided and analyzed with the help of graphs, tables, and pie-charts.

The report also identifies growth drivers, inhibitors and opportunities of the peptide therapeutics market, with a detailed section covering the competitive landscape.

Overview of the global peptide therapeutics market
The worldwide market for peptide therapeutics was valued at US$14.1 billion in 2011 and is expected to grow to US$25.4 billion in 2018 at a CAGR of 8.7% during the forecast period.

The prevalence of cancer, Alzheimer’s and Parkinson’s disease, and metabolic disorders has grown in recent years, which has propelled the peptide therapeutics market. Moreover, based on market research, the integration of small peptide therapeutics firms and large pharmaceutical companies will pose tremendous opportunities for growth. In addition to this, possibility of patent cliff in the forecast period is expected to expand the generic peptide segment. 

Advances in technology, increasing R&D activities in the field of peptide therapeutics, and development of cancer vaccines are some of the other forces that drive the global peptide therapeutics market. The factors that restrain the growth of the peptide therapeutics market are difficulties in corresponding equipment with patients’ needs, growing intricacies of peptides, and poor regulatory standards for peptide therapeutics.


Peptide therapeutics are applied in numerous disciplines of medicine such as anti-infection, neurology, cardiovascular, renal, pain, dermatology, respiratory, cancer, gastro intestinal, and metabolic. Of these, cancer peptide enjoys the largest industry share, accounting for 21% of the overall peptide therapeutics market. However, with increasing prevalence of Alzheimer’s and Parkinson’s disease, the neuropeptide segment is expected to witness rapid growth in the forecast period. Among the major routes of peptide therapeutics administration, the parenteral segment made up for 86% of the market share in 2011. Globally, North America dominates the global peptide therapeutics market, making up 40% of the overall industry.



Companies mentioned in the research report

The vendors operating in the global peptide therapeutics market include F. Hoffmann La Roche Ltd., Novo-Nordisk A/S, Eli Lilly and Company, Ipsen, and Amylin Pharmaceuticals LLC (Bristol-Myers Squibb). The CMOs in the global peptide therapeutics market include Peptisyntha, Inc., Lonza, Inc., Bachem Holding AG, and PolyPeptide Group.



Major geographies analyzed under this research report are:

Europe

• North America
  
• Asia-Pacific
  
• Rest of the World
  

This report gives you access to decisive data such as:

• Market growth drivers
  

• Factors limiting market growth
  
• Current market trends
  
• Market structure
  
• Market projections for the coming years
  
• 
  

Key highlights of this report:

• Overview of key market forces propelling and restraining market growth
  
• Up-to-date analyses of market trends and technological improvements in the micro servers industry
  
• Pin-point analyses of market competition dynamics to offer you a competitive edge
  
• An analysis of strategies of major competitors
  
• An array of graphics and SWOT analysis of major industry segments
  
• Detailed analyses of industry trends
  
• A well-defined technological growth map with an impact-analysis
  
• Offers a clear understanding of the competitive landscape and key product segments
  

Sample Report:http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=418



About Us :

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Stem Cells Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 – 2018

The surge in therapeutic research activities led by government support across the world has spurred the growth of the global stem cells market. The research report on the stem cells industry gives a clear understanding of the structure, scope, and dynamics of the market and provides sharp insights on the same.



Browse Report:http://www.transparencymarketresearch.com/stem-cells-market.html



The report provides historic, current, and future data associated with the stem cell market size, share, annual growth, trends, key established and emerging market areas, and potential stem cell markets. With the help of graphs and tables, the report presents estimates and forecasts in a crisp and clear format. Using Porter’s five forces analysis, the report discusses the competitive landscape of the stem cells market, and provides a comprehensive evaluation of the leading market players.



The research report aims to help entities make well-informed business decisions based on accurate data and expert analysis.


Overview of the global stem cells market
The worldwide market for stem cells was worth US$26.23 billion in 2013 and, growing at a 24.2% CAGR, is expected to reach an approximate value of US$119.52 billion by 2019.



As the prevalence of chronic diseases and rate of unmet medical needs grows, so does the number of research activities in the field of stem cells. Government support and funds in the development and clinical research of stem cells has fostered the growth of the stem cells market. In addition, there has been an increase in awareness regarding regenerative treatment options, stem cell banking services, and the need for stem cells in drug discovery and screening. Medical tourism hubs in developing countries such as India, China, Mexico, Brazil, and Malaysia have further helped the growth of the stem cells market especially in Asia and Latin America. There are numerous opportunities that present themselves before the stem cells market such as growth of the contract research industry, rising disposable income in emerging countries, replacing animal tissue in drug discovery, and increasing number of patients with neurodegenerative diseases.



On the other hand, stringent government regulations against the harvesting of stem cells and high cost of treatment are expected to stall the growth of the global market.



The stem cells industry is highly diversified and fragmented, and can be segmented on the basis of products, technology, applications, and geography. The major stem cell product types are human embryonic stem cells, induced pluripotent stem cells, very small embryonic-like stem cells, rat neural stem cells, and adult stem cells. The main technology sub-segments include stem cell cryopreservation, stem cells expansion and sub-culture, stem cell acquisition, and stem cell production. Stem cells find applications in two key sectors: drug discovery and development, and regenerative medicines.



Request a Sample of this Report:http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=132



Companies mentioned in the research report



The global stem cells market is prospering with numerous small and big players operating within the industry. Some of the key stem cells market players include Advanced Cell Technology, Celgene Corporation Inc., Cellartis AB, Brainstorm Cell Therapeutics, Biotime Inc., Osiris Therapeutics, California Stem Cell Inc., Angel Biotechnology, Bioheart, Cellular Engineering Technologies, Stemcelltechnologies Inc., and Cytori Therapeutics Inc.



Major geographies analyzed under this research report are:
Europe
North America
Asia-Pacific
Rest of the World



This report gives you access to decisive data such as:
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for the coming years



Key highlights of this report
Overview of key market forces propelling and restraining market growth
Up-to-date analyses of market trends and technological improvements in the micro servers industry
Pin-point analyses of market competition dynamics to offer you a competitive edge
An analysis of strategies of major competitors
An array of graphics and SWOT analysis of major industry segments
Detailed analyses of industry trends
A well-defined technological growth map with an impact-analysis
Offers a clear understanding of the competitive landscape and key product segment\



Request for discount on this Report :http://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=132

About us:

Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact:

Transparency Market Research

90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012- 2018

With growing incidences of cancer, Parkinson’s and Alzheimer’s disease, and metabolic disorders, the global peptide therapeutics market has received a significant boost. The application of peptide therapeutics in the field of biotechnology and pharmaceuticals offers tremendous potential as an emerging market and the research report analyses the numerous possibilities that lie before the global peptide therapeutics market.

Browse Report:http://www.transparencymarketresearch.com/peptide-therapeutics-market.html

Categorizing the peptide therapeutics market on the basis of type, application, route of administration, technology, and geography, the report individually evaluates each segment of the peptide therapeutics industry and offers key insights on the same. Data on key aspects such as market size, value, industry share, global outlook, trends, and past, current, and future statistics of the global peptide therapeutics market have been provided and analyzed with the help of graphs, tables, and pie-charts.

The report also identifies growth drivers, inhibitors and opportunities of the peptide therapeutics market, with a detailed section covering the competitive landscape.

Overview of the global peptide therapeutics market
The worldwide market for peptide therapeutics was valued at US$14.1 billion in 2011 and is expected to grow to US$25.4 billion in 2018 at a CAGR of 8.7% during the forecast period.

The prevalence of cancer, Alzheimer’s and Parkinson’s disease, and metabolic disorders has grown in recent years, which has propelled the peptide therapeutics market. Moreover, based on market research, the integration of small peptide therapeutics firms and large pharmaceutical companies will pose tremendous opportunities for growth. In addition to this, possibility of patent cliff in the forecast period is expected to expand the generic peptide segment. Advances in technology, increasing R&D activities in the field of peptide therapeutics, and development of cancer vaccines are some of the other forces that drive the global peptide therapeutics market. The factors that restrain the growth of the peptide therapeutics market are difficulties in corresponding equipment with patients’ needs, growing intricacies of peptides, and poor regulatory standards for peptide therapeutics.


Peptide therapeutics are applied in numerous disciplines of medicine such as anti-infection, neurology, cardiovascular, renal, pain, dermatology, respiratory, cancer, gastro intestinal, and metabolic. Of these, cancer peptide enjoys the largest industry share, accounting for 21% of the overall peptide therapeutics market. However, with increasing prevalence of Alzheimer’s and Parkinson’s disease, the neuropeptide segment is expected to witness rapid growth in the forecast period. Among the major routes of peptide therapeutics administration, the parenteral segment made up for 86% of the market share in 2011. Globally, North America dominates the global peptide therapeutics market, making up 40% of the overall industry.


Companies mentioned in the research report


The vendors operating in the global peptide therapeutics market include F. Hoffmann La Roche Ltd., Novo-Nordisk A/S, Eli Lilly and Company, Ipsen, and Amylin Pharmaceuticals LLC (Bristol-Myers Squibb). The CMOs in the global peptide therapeutics market include Peptisyntha, Inc., Lonza, Inc., Bachem Holding AG, and PolyPeptide Group.



Major geographies analyzed under this research report are:

• Europe
  
• North America
  
• Asia-Pacific
  
• Rest of the World
  

This report gives you access to decisive data such as:

• Market growth drivers
  

• Factors limiting market growth
  
• Current market trends
  
• Market structure
  
• Market projections for the coming years
  
• 
  

Key highlights of this report:

• Overview of key market forces propelling and restraining market growth
  
• Up-to-date analyses of market trends and technological improvements in the micro servers industry
  
• Pin-point analyses of market competition dynamics to offer you a competitive edge
  
• An analysis of strategies of major competitors
  
• An array of graphics and SWOT analysis of major industry segments
  
• Detailed analyses of industry trends
  
• A well-defined technological growth map with an impact-analysis
  
• Offers a clear understanding of the competitive landscape and key product segments
  

Sample Report:http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=418



About Us :


Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.



Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Stem Cells Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018

The market growth is majorly attributed to therapeutic research activities led by government support worldwide owing to the growing number of patients with chronic diseases across the globe. In addition, rising awareness of regenerative treatment options and growing importance of stem cell banking services are also fostering the growth of the market. Apart from these, development of medical tourism hubs in developing nations such as India and China and in turn migration of patients from developed nations such as the U.S., and Europe for quality treatment at significantly lower prices will also serve the market as a driver especially for the Asian stem cells market.

Browse the full report at http://www.transparencymarketresearch.com/stem-cells-market.html

Stem cells market will be driven by rising proportion of patients with neurological and other chronic conditions and rising disposable incomes of patients induced by economic growth of Asian regions in the next five years In addition, increasing dependence on stem cells for drug discovery and screening will boost the growth of the market in future. Increased outsourcing of contract research and clinical trials to developing Asian regions will further encourage growth of the stem cells market.

Adult stem cells held majority share of the overall stem cells market in 2011 at over 80%. This is due to less laborious procedure of harvesting, and less probability of contamination during expansion and sub-culture of adult stem cells. However, fewer post-transplant complications and lesser risk of graft vs. host reaction from the recently introduced induced pluripotent stem cells will lead to its rapid inclusion in research activities and help the global induced pluripotent stem cells market to grow at a relatively faster CAGR during the forecast period.

Regenerative medicine dominated the stem cells market by applications in 2011, and is expected to maintain its leading position till 2018. Considerable research activities and the resultant developed therapies in neurology will drive the stem cells market in the forecast period.

North America was the market leader of the total stem cells market in 2011 and is expected to maintain its leading position till 2018. North American market is a center for stem cells research owing to greater support offered by federal government, and higher affordability of treatment in the region. High prevalence of chronic diseases in the region and support in terms of funding from government and private organizations is driving the European stem cells market.

The key players in stem cell research and technology include Advanced Cell Technology Inc., Stem Cell Technologies Inc., Cellular Engineering Technologies Inc., BioTime Inc., and Cellartis Ab among others.

The global stem cells market is categorized into the following segments:

Stem Cells Market by Products

Adult Stem Cells

Hematopoietic Stem Cells

Mesenchymal Stem Cells

Neuronal Stem Cells

Dental Stem Cells

Umbilical Cord Stem Cells

Human Embryonic Stem Cells

Induced Pluripotent Stem Cells

Natural Rosette Cells

Very Small Embryonic-Like Stem Cells

Stem Cells Market by Technology

Cell Acquisition

Bone Marrow Harvest

Apheresis

Umbilical Cord Blood

Cell Production

Therapeutic Cloning

In Vitro Fertilization

Isolation

Cell Culture

Cryopreservation

Expansion and Sub-Culture

Stem Cells Market by Applications

Regenerative Medicine

Neurological Disorders

Orthopedics

Cancer

Hematological disorders

Cardiovascular diseases

Injuries

Wound Care

Spinal Cord Injury

Others (Joint Injuries, Eye Injuries, Lacerations and Concussions)

Diabetes

Liver Disorder

Incontinence

Others (Crohn's Disease, Infertility, Immunodeficiency Disorder, Organ Transplants, Ophthalmic Disorder)

Drug Discovery and Development

Stem Cells Market by Geography

North America

Europe

--Asia

Rest of the World (RoW)

For Sample Report Visit On:

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=132

About Us

Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Companion Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

The research report, titled “Companion Diagnostics Market (Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019”, fully explores current and future possibilities in the growing segment of companion diagnostics.

Browse the full Report at

http://www.transparencymarketresearch.com/companion-diagnostics-market.html

The report states that the companion diagnostics market for breast cancer was the dominant sector in 2012, in terms of revenue. The upcoming sector for the near future is lung cancer. The segment is growing at a CAGR of more than 20% between 2013 and 2019. The report cites reasons for growth as the discovery of lung cancer specific biomarkers, along with a myriad of relevant companion diagnostics.

The largest market according to region in 2012 was North America, with the E.U. in following. The report said that the factors that favored the market’s growth were positive healthcare policies, a growing consumer base, increasing disposable incomes, improvements in healthcare systems, and increased awareness. The acceptance of modern medicine into mainstream sectors in the U.S. and the E.U. are the prime reasons for the growth of this market. The Asia-Pacific region and the Rest of the World regions are set to show considerable growth by the year 2019. The report cites untapped potential, increasing disposable incomes, and an improving healthcare infrastructure.

The report explains that companion diagnostics are tests which assist physicians while making decisions regarding the most efficient treatment methods, depending on responses by the patient over ongoing treatment.

Key restraints as explained by the report include regulatory restrictions, commercialization of companion diagnostics, heavy procedure costs, long phases of approval, and lack of reach towards the low income countries.

Key companies in the companion diagnostics market include Quagen N.V., Abbott Laboratories, Life Technologies, Genomic Health, Inc., GE Healthcare Ltd., Roche Holdings AG, Agilent Technologies, Inc., and Agendia N.V.

The report provides exhaustive details on the companion diagnostics market by segmenting it according to indications and geography. By indications, the market is classified into breast cancer, lung cancer, melanoma, gastric cancer, colorectal cancer, and others such as HIV and thalassemia. According to geography, the reports details North America, Europe, Asia-Pacific, and Rest of the World.

About Us

Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

C